AVTR Avantor, Inc.

NYSE · US · Healthcare · Medical Instruments & Supplies · avantorsciences.com

15.81USD+3.06%Mkt Cap: 10.69B $P/E: —1d ago

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the America…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$143.60BUSDP/E 46.6

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$26.51BUSDP/E 48.2

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation

$14.98BUSDP/E 10.8

BAX

Baxter International Inc.

$12.52BUSD

COO

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Bausch + Lomb Corporation

$6.13BUSD

Key Statistics

Company

Market Cap10.69B USD

Enterprise Value13.77B USD

Revenue (TTM)6.56B USD

Gross Profit2.14B USD

Net Income (TTM)-530.20M USD

Revenue/Share9.68 USD

Last Price15.81 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees13.5K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)17.49

PEG—

EV/EBITDA14.59

EV/Revenue2.10

P/S1.58

P/B1.84

EPS (TTM)-0.84

EPS (Forward)0.88

52W Range

7.26597% of range16.05

52W High16.05 USD

52W Low7.265 USD

Profitability

Gross Margin32.65%

Oper. Margin7.16%

EBITDA Margin14.38%

Profit Margin-8.09%

ROE-9.53%

ROA-4.50%

Growth

Revenue Growth0.50%

Earnings Growth-37.40%

Cash Flow & Leverage

Operating CF623.80M USD

CapEx (TTM)128.80M USD

FCF Margin6.86%

FCF Yield4.21%

Net Debt3.39B USD

Net Debt/EBITDA3.59

Balance Sheet

Debt/Equity0.71

Current Ratio1.78

Quick Ratio1.05

Book Value/Sh8.32 USD

Cash/Share0.45 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating2.8 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)14.56 USD

Upside (mean)-7.9%

Target Range12.00 USD – 19.00 USD

12.00-7.9% to mean19.00

# Analysts14

Ownership

Shares Out.676.36M

Float657.81M

Insiders1.53%

Institutions105.30%

Short Interest

Short Ratio7.3d

Short % Float9.22%

Short % Out.7.60%

Shares Short51.37M

Short (prev mo.)52.19M

Technical

SMA 5014.37 (+10.1%)

SMA 20010.74 (+47.3%)

Beta0.90

S&P 52W Chg14.58%

Avg Vol (30d)8.09M

Avg Vol (10d)8.56M

Technical Indicators

RSI (14)64.1

MACD0.3149

MACD Signal0.3659

MACD Hist.-0.0511

BB Upper15.86 USD

BB Middle15.23 USD

BB Lower14.60 USD

BB Width8.23%

ATR (14)0.4639 USD

Vol Ratio (20d)0.89x